Literature DB >> 18068618

Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.

Stein Orn1, Cord Manhenke, Iain B Squire, Leong Ng, Inder Anand, Kenneth Dickstein.   

Abstract

BACKGROUND: Altered activity of the matrix metalloproteinases (MMP-2 and -9), has been implicated in the left ventricular (LV) remodeling process occurring after myocardial infarction (MI). In the acute phase, a relation between plasma MMP-9 levels and parameters of LV dysfunction has been demonstrated. The relationship in long-term survivors has not been investigated. We studied the relationships of these biochemical markers, and N-terminal pro-B-type natriuretic peptide (N-BNP), with measures of long-term LV remodeling. METHODS AND
RESULTS: Plasma levels of N-BNP, MMP-2, and MMP-9 were measured at randomization, 1 month, 1 year, and > 4 years after complicated AMI. Contrast-enhanced cardiac magnetic resonance (CMR) was performed at 4.4 (+/-0.4) years in 52 clinically stable long-term survivors of the index AMI. We assessed the relationships of plasma N-BNP, MMP-2, and MMP-9 with myocardial scarring, and measures of long-term LV remodeling. Compared with a reference population, N-BNP and MMP-9 levels were increased at all time points from the acute phase until > 4 years after MI. Plasma N-BNP and MMP-9 correlated only in the subacute phase (randomization, mean 3.3 days after MI) days after acute MI (r = 0.38, P = .006). At CMR assessment > or = 4 years, log MMP-9 level was inversely related to LV ejection fraction (P = .002) and nonscarred myocardial mass (P = .008). This relationship was independent of MMP-2. Log N-BNP was related to end diastolic volume index (P = .0002). There was no correlation between log MMP-9 and LV volumes.
CONCLUSION: There is a time-dependent relationship between plasma N-BNP and MMP-9 levels, these peptides correlating only in the acute phase after MI. In long-term follow-up, plasma MMP-9 and N-BNP levels were related to different parameters of LV remodeling. These findings suggest that in long-term survivors of complicated MI, different mechanisms modulate plasma levels of MMP-9 and N-BNP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068618     DOI: 10.1016/j.cardfail.2007.07.006

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  16 in total

1.  Matrix metalloproteinase therapy in heart failure.

Authors:  Francis G Spinale; Nikole M Wilbur
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08

2.  Association of polymorphisms of zinc metalloproteinases with clinical response to stem cell therapy.

Authors:  R Panovsky; A Vasku; J Meluzin; M Kaminek; J Mayer; S Janousek; V Kincl; L Groch; M Navratil
Journal:  Herz       Date:  2010-08       Impact factor: 1.443

3.  Elevated serum matrix metalloproteinase-2 levels in heart failure patients with reduced ejection fraction and Cheyne-Stokes respiration.

Authors:  Li-Pang Chuang; Jong-Hwei S Pang; Shih-Wei Lin; Kuo-Chun Hung; Han-Chung Hu; Kuo-Chin Kao; Ming-Shien Wen; Ning-Hung Chen
Journal:  J Clin Sleep Med       Date:  2022-05-01       Impact factor: 4.324

4.  ZAK induces MMP-2 activity via JNK/p38 signals and reduces MMP-9 activity by increasing TIMP-1/2 expression in H9c2 cardiomyoblast cells.

Authors:  Yi-Chang Cheng; Wei-Wen Kuo; Hsi-Chin Wu; Tung-Yuan Lai; Chun-Hsien Wu; Jin-Ming Hwang; Wen-Hong Wang; Fuu-Jen Tsai; Jaw-Ji Yang; Chih-Yang Huang; Chun-Hsien Chu
Journal:  Mol Cell Biochem       Date:  2009-01-28       Impact factor: 3.396

Review 5.  Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates.

Authors:  Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yu-Fang Jin; Merry L Lindsey
Journal:  Circ Res       Date:  2014-02-28       Impact factor: 17.367

Review 6.  Integrating the myocardial matrix into heart failure recognition and management.

Authors:  Francis G Spinale; Michael R Zile
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

Review 7.  Structural aspects of Golgi function.

Authors:  R S Polishchuk; A A Mironov
Journal:  Cell Mol Life Sci       Date:  2004-01       Impact factor: 9.261

8.  Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker.

Authors:  Efstathios Vassiliadis; Lars M Rasmussen; Inger Byrjalsen; Dorthe Vang Larsen; Rajiv Chaturvedi; Susanne Hosbond; Lotte Saabye; Axel C P Diederichsen; Federica Genovese; Kevin L Duffin; Qinlong Zheng; Xiaoliang Chen; Diana J Leeming; Claus Christiansen; Morten A Karsdal
Journal:  J Transl Med       Date:  2012-07-06       Impact factor: 5.531

9.  Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAs.

Authors:  Helene Skjøt-Arkil; Rikke E Clausen; Lars M Rasmussen; Wanchun Wang; Yaguo Wang; Qinlong Zheng; Hans Mickley; Lotte Saaby; Axel C P Diederichsen; Jess Lambrechtsen; Fernando J Martinez; Cory M Hogaboam; Meilan Han; Martin R Larsen; Arkadiusz Nawrocki; Ben Vainer; Dorrit Krustrup; Marina Bjørling-Poulsen; Morten A Karsdal; Diana J Leeming
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

10.  Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction.

Authors:  Tetsuji Morishita; Hiroyasu Uzui; Yasuhiko Mitsuke; Kenichi Arakawa; Naoki Amaya; Kenichi Kaseno; Kentaro Ishida; Reiko Nakaya; Jong-Dae Lee; Hiroshi Tada
Journal:  J Am Heart Assoc       Date:  2015-01-23       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.